
Valproate Hepatotoxicity in Children with Epilepsy
Abstract
Authors from the University Children’s Hospital in Heidelberg estimate the incidence of fatal valproate (VPA) hepatotoxicity in West Germany at around 1 in 5000 and find it hard to justify the use of VPA as a drug of first choice for children with generalised epilepsies.
DOI: https://doi.org/10.15844/pedneurbriefs-1-1-2 | Journal eISSN: 2166-6482
Language: English
Page range: 1 - 2
Published on: Jun 1, 1987
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1987 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.